...
首页> 外文期刊>Circulation journal >A Randomized Controlled Study of Finerenone vs. Eplerenone in Japanese Patients With Worsening Chronic Heart Failure and Diabetes and/or Chronic Kidney Disease
【24h】

A Randomized Controlled Study of Finerenone vs. Eplerenone in Japanese Patients With Worsening Chronic Heart Failure and Diabetes and/or Chronic Kidney Disease

机译:日本慢性心力衰竭加重和/或糖尿病和/或慢性肾脏病患者中呋内酯与依普利酮的随机对照研究

获取原文
获取原文并翻译 | 示例
           

摘要

Background: Finerenone, a nonsteroidal mineralocorticoid receptor antagonist, was evaluated in Japanese patients with heart failure (HF) with reduced ejection fraction and chronic kidney disease and/or diabetes mellitus.
机译:背景:Finerenone是一种非甾体类盐皮质激素受体拮抗剂,在射血分数降低,慢性肾脏疾病和/或糖尿病的日本心力衰竭(HF)患者中进行了评估。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号